Eastman Chemical (EMN) Director Defers Fees into Stock Units
EASTMAN CHEMICAL CO
Subscribe to track EMN
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Eastman Chemical (EMN) Director Defers Fees into Stock Units
Company: EASTMAN CHEMICAL CO (EMN) Form: 4 | Filed: 2025-10-09 Significance: Low
Insider: Haynesworth Linnie M Title: null | Relationship: Director
Transaction: • Type: Grant • Shares: 487 Phantom Stock Units • Price: $0.00 • Value: $0 • Owned After: 3,559
Key Insight: This is a routine, non-discretionary transaction where a director automatically deferred annual retainer fees into phantom stock units, as per the company's compensation plan. It does not represent a new investment decision.
Market Context: Such compensation-related acquisitions are common and typically have a neutral impact on the market as they don't reflect active insider sentiment.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: EASTMAN CHEMICAL CO (EMN)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director received phantom stock units as part of an automatic deferral of annual retainer fees, a routine compensation-related event with no new investment signal.
- Market Impact: Neutral. This type of transaction is standard for director compensation and is not expected to influence market sentiment or trading volume.
Company Information
| Field | Value |
|---|---|
| Company | EASTMAN CHEMICAL CO |
| Ticker Symbol | EMN |
| CIK | 0000915389 |
| Industry | Plastics, Materials, Synth Resins & Nonvulcan Elastomers [2821] |
Insider Information
| Field | Value |
|---|---|
| Name | Haynesworth Linnie M |
| CIK | 0001790292 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-07 |
| Transaction Code | A (Award) |
| Security Type | Phantom Stock Units |
| Shares Involved | 487 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 3,559 |
| Ownership Type | Direct |
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is an automatic, non-discretionary acquisition as part of a director's compensation plan. It does not reflect a proactive decision by the insider to increase their stake based on company performance or outlook. The market typically does not react to such routine filings.
Volume & Sentiment
- Expected Volume Impact: Negligible. Compensation-related grants do not affect trading volume on the open market.
- Sentiment Indicator: Neutral. This filing does not provide any bullish or bearish signals.
Investment Insights
Positive Market Indicators
- The structure of deferring fees into stock-equivalent units aligns the director's interests with shareholders over the long term.
Risk Factors
- No new risk factors are indicated by this filing. The transaction is routine.
Key Takeaways
- Routine Compensation: The acquisition of 487 phantom stock units is an automatic deferral of director fees, not an open-market purchase.
- No New Signal: With a transaction value of $0 and its non-discretionary nature, this filing provides no insight into the director's current sentiment on the company's valuation or future prospects.
- Cash-Settled Units: The phantom stock units are payable only in cash after the director's service terminates, meaning they will not convert to common stock to be sold on the open market.
Contextual Analysis
Timing Significance
- The timing of the transaction is tied to the company's director compensation schedule and is not indicative of any strategic market timing.
Transaction Context
- As noted in Footnote 2, this was an "Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan, which would otherwise have been paid in cash." This confirms the non-discretionary and routine nature of the event.
Company Context
- This filing should be viewed in the context of Eastman Chemical's standard corporate governance and executive compensation practices. It does not relate to any specific operational news or recent company developments.
Risk Assessment
Risk Level: Low
Risk Factors
- The filing itself presents no new risks to investors.
Market Considerations
- Investors should differentiate between discretionary open-market trades and non-discretionary compensation-related filings like this one.
- The increase in the director's holdings is nominal and part of a pre-established plan.
IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.
Analysis generated on 2025-10-09 | Data source: SEC EDGAR
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.